BDI マネジメント

マネジメント基準チェック /04

現在、CEO に関する十分な情報がありません。

主要情報

最高経営責任者

n/a

報酬総額

CEO給与比率	n/a
CEO在任期間	no data
CEOの所有権	n/a
経営陣の平均在職期間	データなし
取締役会の平均在任期間	データなし

経営陣の近況

更新なし

Recent updates

The BDI (KOSDAQ:148140) Share Price Is Up 53% And Shareholders Are Holding On

Jan 18

CEO（最高経営責任者

BDI CEOがいない、あるいは彼らに関するデータがない。

BDI マネジメント

マネジメント基準チェック /04

主要情報

経営陣の近況

Recent updates

New major risk - Financial position

New major risk - Market cap size

New major risk - Negative shareholders equity

BDI CO., LTD. announced that it expects to receive KRW 2 billion in funding

BDI CO., LTD. announced that it has received KRW 8.099998751 billion in funding

BDI CO., LTD. has completed a Follow-on Equity Offering in the amount of KRW 45.7 billion.

Full year 2020 earnings released: ₩6,049 loss per share (vs ₩8.00 loss in FY 2019)

BDI CO., LTD. announced that it expects to receive KRW 50 billion in funding

The BDI (KOSDAQ:148140) Share Price Is Up 53% And Shareholders Are Holding On

New 90-day high: ₩6,480

BDI CO., LTD. announced that it has received KRW 6.5 billion in funding from Samsung Securities Co.,Ltd., Shinhan Investment Corp.

Il-Kang Kim, Chief Executive Officer of BDI CO., LTD. completed the acquisition of 22.5% stake in BDI CO., LTD. (KOSDAQ:A148140) from Seungman Ahn and Kyung-Soon Lee for KRW 38 billion.

New 90-day low - ₩5,700

BDI CO., LTD. announced that it has received KRW 10.1 billion in funding

BDI CO., LTD. (KOSDAQ:A148140) entered into an agreement to acquire Eleison Pharmaceuticals Inc. for $20.9 million.

CEO（最高経営責任者

BDI マネジメント

マネジメント 基準チェック /04

主要情報

経営陣の近況

Recent updates

New major risk - Financial position

New major risk - Market cap size

New major risk - Negative shareholders equity

BDI CO., LTD. announced that it expects to receive KRW 2 billion in funding

BDI CO., LTD. announced that it has received KRW 8.099998751 billion in funding

BDI CO., LTD. has completed a Follow-on Equity Offering in the amount of KRW 45.7 billion.

Full year 2020 earnings released: ₩6,049 loss per share (vs ₩8.00 loss in FY 2019)

BDI CO., LTD. announced that it expects to receive KRW 50 billion in funding

The BDI (KOSDAQ:148140) Share Price Is Up 53% And Shareholders Are Holding On

New 90-day high: ₩6,480

BDI CO., LTD. announced that it has received KRW 6.5 billion in funding from Samsung Securities Co.,Ltd., Shinhan Investment Corp.

Il-Kang Kim, Chief Executive Officer of BDI CO., LTD. completed the acquisition of 22.5% stake in BDI CO., LTD. (KOSDAQ:A148140) from Seungman Ahn and Kyung-Soon Lee for KRW 38 billion.

New 90-day low - ₩5,700

BDI CO., LTD. announced that it has received KRW 10.1 billion in funding

BDI CO., LTD. (KOSDAQ:A148140) entered into an agreement to acquire Eleison Pharmaceuticals Inc. for $20.9 million.

CEO（最高経営責任者

マネジメント基準チェック /04